Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions
- PMID: 21077975
- PMCID: PMC3227547
- DOI: 10.1111/j.1360-0443.2010.03194.x
Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Abstract
Aim: To estimate the general and racial/ethnic specific cumulative probability of remission from nicotine alcohol cannabis or cocaine dependence, and to identify predictors of remission across substances.
Design: Data were collected from structured diagnostic interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV version.
Setting: The 2001-2002 National Epidemiological Survey of Alcohol and Related Conditions (NESARC) surveyed a nationally representative sample from US adults (n = 43,093) selected in a three-stage sampling design.
Participants: The subsamples of individuals with life-time DSM-IV diagnosis of dependence on nicotine (n = 6937), alcohol (n = 4781), cannabis (n = 530) and cocaine (n = 408).
Measurements: Cumulative probability estimates of dependence remission for the general population and across racial/ethnic groups. Hazard ratios for remission from dependence.
Findings: Life-time cumulative probability estimates of dependence remission were 83.7% for nicotine, 90.6% for alcohol, 97.2% for cannabis and 99.2% for cocaine. Half of the cases of nicotine, alcohol, cannabis and cocaine dependence remitted approximately 26, 14, 6 and 5 years after dependence onset, respectively. Males, Blacks and individuals with diagnosis of personality disorders and history of substance use comorbidity exhibited lower hazards of remission for at least two substances.
Conclusions: A significant proportion of individuals with dependence on nicotine, alcohol, cannabis or cocaine achieve remission at some point in their life-time, although the probability and time to remission varies by substance and racial/ethnic group. Several predictors of remission are shared by at least two substances, suggesting that the processes of remission overlap. The lower rates of remission of individuals with comorbid personality or substance use disorders highlight the need for providing coordinated psychiatric and substance abuse interventions.
© 2010 The Authors. Addiction © 2010 Society for the Study of Addiction.
Figures





Comment in
-
Commentary on Lopez-Quintero et al. (2011): Remission and relapse - the Yin-Yang of addictive disorders.Addiction. 2011 Mar;106(3):670-1. doi: 10.1111/j.1360-0443.2010.00003284.x. Addiction. 2011. PMID: 21299675 No abstract available.
References
-
- Rehm J, Taylor B, Room R. Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev. 2006;25:503–513. - PubMed
-
- Newcomb MD, Galaif ER, Locke TF. Substance use diagnosis within a community sample of adults: Distinction, comorbidity, and progression over time. Prof Psychol-Res Pr. 2001;32:239–247.
-
- Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry. 2001;58:810–816. - PubMed
-
- de Bruijn C, van den Brink W, de Graaf R, Vollebergh WA. The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. Addiction. 2006;101:385–392. - PubMed
Publication types
MeSH terms
Grants and funding
- MH076051/MH/NIMH NIH HHS/United States
- K02 DA023200/DA/NIDA NIH HHS/United States
- U01 AA018111/AA/NIAAA NIH HHS/United States
- R01 CA133050/CA/NCI NIH HHS/United States
- CA133050/CA/NCI NIH HHS/United States
- DA023200/DA/NIDA NIH HHS/United States
- R01 DA020783/DA/NIDA NIH HHS/United States
- MH082773/MH/NIMH NIH HHS/United States
- R01 DA019606/DA/NIDA NIH HHS/United States
- R01 MH082773/MH/NIMH NIH HHS/United States
- DA018652/DA/NIDA NIH HHS/United States
- R01 DA023973/DA/NIDA NIH HHS/United States
- AA018111/AA/NIAAA NIH HHS/United States
- R01 MH076051/MH/NIMH NIH HHS/United States
- DA019606/DA/NIDA NIH HHS/United States
- R01 DA018652/DA/NIDA NIH HHS/United States
- AA014223/AA/NIAAA NIH HHS/United States
- DA023973/DA/NIDA NIH HHS/United States
- K05 AA014223/AA/NIAAA NIH HHS/United States
- DA020783/DA/NIDA NIH HHS/United States